First National Trust Co Has $6.32 Million Stock Holdings in Cardinal Health, Inc. $CAH

First National Trust Co lifted its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 0.3% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 37,608 shares of the company’s stock after buying an additional 98 shares during the period. First National Trust Co’s holdings in Cardinal Health were worth $6,318,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of CAH. GAMMA Investing LLC increased its holdings in Cardinal Health by 28.4% in the 1st quarter. GAMMA Investing LLC now owns 7,004 shares of the company’s stock worth $965,000 after purchasing an additional 1,549 shares in the last quarter. Golden State Wealth Management LLC increased its stake in shares of Cardinal Health by 569.5% in the first quarter. Golden State Wealth Management LLC now owns 395 shares of the company’s stock valued at $54,000 after buying an additional 336 shares during the period. Perigon Wealth Management LLC increased its stake in shares of Cardinal Health by 4.2% in the first quarter. Perigon Wealth Management LLC now owns 2,242 shares of the company’s stock valued at $309,000 after buying an additional 90 shares during the period. Amalgamated Bank increased its stake in shares of Cardinal Health by 1.2% in the first quarter. Amalgamated Bank now owns 53,338 shares of the company’s stock valued at $7,348,000 after buying an additional 619 shares during the period. Finally, Valley National Advisers Inc. increased its stake in shares of Cardinal Health by 2.3% in the first quarter. Valley National Advisers Inc. now owns 16,366 shares of the company’s stock valued at $2,254,000 after buying an additional 367 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Trading Up 1.2%

Shares of Cardinal Health stock opened at $163.76 on Tuesday. The business has a 50-day moving average price of $153.04 and a two-hundred day moving average price of $153.26. Cardinal Health, Inc. has a 1-year low of $106.98 and a 1-year high of $168.44. The company has a market cap of $38.91 billion, a P/E ratio of 25.39, a PEG ratio of 1.37 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same period last year, the business posted $1.84 EPS. The business’s revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were given a dividend of $0.5107 per share. The ex-dividend date of this dividend was Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.2%. Cardinal Health’s dividend payout ratio (DPR) is 31.63%.

Wall Street Analysts Forecast Growth

CAH has been the subject of several recent research reports. Leerink Partners upped their price target on shares of Cardinal Health from $186.00 to $187.00 and gave the company an “outperform” rating in a research report on Monday, October 6th. Wall Street Zen downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 2nd. UBS Group reissued a “buy” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Wells Fargo & Company reissued an “overweight” rating and issued a $185.00 price target (up previously from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Finally, Jefferies Financial Group set a $150.00 price target on Cardinal Health in a research note on Tuesday, August 12th. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and an average target price of $166.00.

Insider Activity at Cardinal Health

In other news, CEO Stephen M. Mason sold 41,575 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer owned 26,085 shares of the company’s stock, valued at $3,881,969.70. This trade represents a 61.45% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Jason M. Hollar sold 35,901 shares of the firm’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total transaction of $5,386,586.04. Following the sale, the chief executive officer directly owned 200,000 shares of the company’s stock, valued at approximately $30,008,000. This trade represents a 15.22% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 271,676 shares of company stock worth $40,489,525. Corporate insiders own 0.12% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.